These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25749516)

  • 1. ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients.
    Vargas T; Moreno-Rubio J; Herranz J; Cejas P; Molina S; González-Vallinas M; Mendiola M; Burgos E; Aguayo C; Custodio AB; Machado I; Ramos D; Gironella M; Espinosa-Salinas I; Ramos R; Martín-Hernández R; Risueño A; De Las Rivas J; Reglero G; Yaya R; Fernández-Martos C; Aparicio J; Maurel J; Feliu J; Ramírez de Molina A
    Oncotarget; 2015 Mar; 6(9):7348-63. PubMed ID: 25749516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
    Alajez NM
    PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional and mutational landscapes of lipid metabolism-related genes in colon cancer.
    Fernández LP; Ramos-Ruiz R; Herranz J; Martín-Hernández R; Vargas T; Mendiola M; Guerra L; Reglero G; Feliu J; Ramírez de Molina A
    Oncotarget; 2018 Jan; 9(5):5919-5930. PubMed ID: 29464044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer.
    Maak M; Simon I; Nitsche U; Roepman P; Snel M; Glas AM; Schuster T; Keller G; Zeestraten E; Goossens I; Janssen KP; Friess H; Rosenberg R
    Ann Surg; 2013 Jun; 257(6):1053-8. PubMed ID: 23295318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.
    Kopetz S; Tabernero J; Rosenberg R; Jiang ZQ; Moreno V; Bachleitner-Hofmann T; Lanza G; Stork-Sloots L; Maru D; Simon I; Capellà G; Salazar R
    Oncologist; 2015 Feb; 20(2):127-33. PubMed ID: 25561511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer.
    Vargas T; Moreno-Rubio J; Herranz J; Cejas P; Molina S; González-Vallinas M; Ramos R; Burgos E; Aguayo C; Custodio AB; Reglero G; Feliu J; Ramírez de Molina A
    Mol Oncol; 2014 Dec; 8(8):1469-81. PubMed ID: 25001263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
    Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
    Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular signature for the prediction of recurrence in colorectal cancer.
    Wang L; Shen X; Wang Z; Xiao X; Wei P; Wang Q; Ren F; Wang Y; Liu Z; Sheng W; Huang W; Zhou X; Du X
    Mol Cancer; 2015 Feb; 14(1):22. PubMed ID: 25645394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
    Smith JJ; Deane NG; Wu F; Merchant NB; Zhang B; Jiang A; Lu P; Johnson JC; Schmidt C; Bailey CE; Eschrich S; Kis C; Levy S; Washington MK; Heslin MJ; Coffey RJ; Yeatman TJ; Shyr Y; Beauchamp RD
    Gastroenterology; 2010 Mar; 138(3):958-68. PubMed ID: 19914252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
    Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
    J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
    Jiang C; Liu Y; Wen S; Xu C; Gu L
    Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer.
    Le Du F; Gonzalez-Angulo AM; Park M; Liu DD; Hortobagyi GN; Ueno NT
    Clin Breast Cancer; 2015 Dec; 15(6):458-66. PubMed ID: 26233757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.